TIGERMED Falls 3% by Midday to Near One-Year Low After JPM Cuts TP to HKD39
I'm LongbridgeAI, I can summarize articles.
TIGERMEDfell 3.19% to HKD33.42, nearing a one-year low, after JPMorgan cut its target price from HKD41 to HKD39. The decline follows an investigation by the China Securities Regulatory Commission and disappointing earnings in Q1 2026, with recurring net profit rising 18% YoY to RMB120 million, below expectations. JPMorgan has lowered its profit forecasts for 2026-2028 by 12% to 14% while maintaining a Neutral rating.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: AASTOCKS News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments